US5776434A
(en)
|
1988-12-06 |
1998-07-07 |
Riker Laboratories, Inc. |
Medicinal aerosol formulations
|
DE4003270A1
(de)
|
1990-02-03 |
1991-08-08 |
Boehringer Ingelheim Kg |
Neue treibgase und ihre verwendung in arzneimittelzubereitungen
|
AU654813B2
(en)
*
|
1990-03-23 |
1994-11-24 |
Minnesota Mining And Manufacturing Company |
The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
|
US5126123A
(en)
*
|
1990-06-28 |
1992-06-30 |
Glaxo, Inc. |
Aerosol drug formulations
|
PT98105B
(pt)
*
|
1990-06-28 |
1998-11-30 |
Glaxo Inc |
Processo para a preparacao de formulacoes em aerossol contendo como propulsor 1,1,1,2-tetrafluoroetano
|
MX9203481A
(es)
|
1990-10-18 |
1992-07-01 |
Minnesota Mining & Mfg |
Formulaciones.
|
DE69105212T2
(de)
*
|
1990-10-18 |
1995-03-23 |
Minnesota Mining & Mfg |
Aerosolzubereitung, die beclometason 17,21-dipropionat enthält.
|
GB9024366D0
(en)
*
|
1990-11-09 |
1991-01-02 |
Glaxo Group Ltd |
Medicaments
|
GB9103824D0
(en)
*
|
1991-02-23 |
1991-04-10 |
Fisons Ag |
Formulation
|
DE69231991T2
(de)
|
1991-06-10 |
2002-04-04 |
Schering Corp |
Fluorchlorkohlenwasserstofffreie Aerosolformulierungen
|
PT656207E
(pt)
*
|
1991-06-10 |
2001-11-30 |
Schering Corp |
Formulacoes de aerossois sem clorofluorocarbonetos
|
US6123924A
(en)
*
|
1991-09-25 |
2000-09-26 |
Fisons Plc |
Pressurized aerosol inhalation compositions
|
IL103238A
(en)
|
1991-09-25 |
1995-07-31 |
Fisons Plc |
Pressed aerosol preparations
|
GB9202522D0
(en)
*
|
1992-02-06 |
1992-03-25 |
Glaxo Group Ltd |
Medicaments
|
US5736124A
(en)
*
|
1991-12-12 |
1998-04-07 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicament
|
IL104068A
(en)
*
|
1991-12-12 |
1998-10-30 |
Glaxo Group Ltd |
Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
|
US5674471A
(en)
*
|
1991-12-12 |
1997-10-07 |
Glaxo Group Limited |
Aerosol formulations containing P134a and salbutamol
|
ATE128350T1
(de)
*
|
1991-12-12 |
1995-10-15 |
Glaxo Group Ltd |
Pharmazeutische aerosolformulierung.
|
US5653962A
(en)
*
|
1991-12-12 |
1997-08-05 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicaments
|
US5744123A
(en)
*
|
1991-12-12 |
1998-04-28 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicaments
|
US5916540A
(en)
*
|
1994-10-24 |
1999-06-29 |
Glaxo Group Limited |
Aerosol formulations containing P134A and/or P227 and particulate medicament
|
AU663905B2
(en)
|
1991-12-12 |
1995-10-26 |
Glaxo Group Limited |
Medicaments
|
US5658549A
(en)
*
|
1991-12-12 |
1997-08-19 |
Glaxo Group Limited |
Aerosol formulations containing propellant 134a and fluticasone propionate
|
US7101534B1
(en)
|
1991-12-18 |
2006-09-05 |
3M Innovative Properties Company |
Suspension aerosol formulations
|
US5376359A
(en)
*
|
1992-07-07 |
1994-12-27 |
Glaxo, Inc. |
Method of stabilizing aerosol formulations
|
ES2064244B1
(es)
*
|
1992-12-02 |
1995-09-01 |
Fisons Plc |
Composiciones de aerosol presurizadas.
|
DE59400836D1
(de)
*
|
1993-01-19 |
1996-11-21 |
Hoechst Ag |
Flüssiggasformulierung zur Vitalitätsprüfung von Zähnen
|
FR2701859B1
(fr)
*
|
1993-02-23 |
1995-04-28 |
Lenglen Jean Luc |
Procédé pour mélanger un gaz avec au moins un liquide.
|
DE4323636A1
(de)
*
|
1993-07-15 |
1995-01-19 |
Hoechst Ag |
Arzneistoffzubereitungen aus umhüllten, schwerstwasserlöslichen Arzneistoffen für Inhalationsarzneiformen und Verfahren zu ihrer Herstellung
|
GB9322014D0
(en)
|
1993-10-26 |
1993-12-15 |
Co Ordinated Drug Dev |
Improvements in and relating to carrier particles for use in dry powder inhalers
|
DE69432224T2
(de)
*
|
1993-12-02 |
2003-12-04 |
Abbott Lab |
Aerosole als darreichungsform mit cfc-freiem treibmittel
|
GB9419536D0
(en)
*
|
1994-09-28 |
1994-11-16 |
Glaxo Inc |
Medicaments
|
GB9501841D0
(en)
*
|
1995-01-31 |
1995-03-22 |
Co Ordinated Drug Dev |
Improvements in and relating to carrier particles for use in dry powder inhalers
|
GB9507768D0
(en)
|
1995-04-13 |
1995-05-31 |
Glaxo Group Ltd |
Method of apparatus
|
US5635161A
(en)
*
|
1995-06-07 |
1997-06-03 |
Abbott Laboratories |
Aerosol drug formulations containing vegetable oils
|
GB9515182D0
(en)
*
|
1995-07-24 |
1995-09-20 |
Co Ordinated Drug Dev |
Improvements in and relating to powders for use in dry powder inhalers
|
GB9526392D0
(en)
|
1995-12-22 |
1996-02-21 |
Glaxo Group Ltd |
Medicaments
|
GB9612297D0
(en)
*
|
1996-06-11 |
1996-08-14 |
Minnesota Mining & Mfg |
Medicinal aerosol formulations
|
US6054488A
(en)
*
|
1996-06-11 |
2000-04-25 |
3M Innovative Properties Company |
Medicinal aerosol formulations of formoterol
|
GB9616237D0
(en)
|
1996-08-01 |
1996-09-11 |
Norton Healthcare Ltd |
Aerosol formulations
|
US6193954B1
(en)
|
1997-03-21 |
2001-02-27 |
Abbott Laboratories |
Formulations for pulmonary delivery of dopamine agonists
|
US6120752A
(en)
*
|
1997-05-21 |
2000-09-19 |
3M Innovative Properties Company |
Medicinal aerosol products containing formulations of ciclesonide and related steroids
|
US20010031244A1
(en)
|
1997-06-13 |
2001-10-18 |
Chiesi Farmaceutici S.P.A. |
Pharmaceutical aerosol composition
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US6433040B1
(en)
|
1997-09-29 |
2002-08-13 |
Inhale Therapeutic Systems, Inc. |
Stabilized bioactive preparations and methods of use
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
GB9805938D0
(en)
|
1998-03-19 |
1998-05-13 |
Glaxo Group Ltd |
Valve for aerosol container
|
US6264923B1
(en)
|
1998-05-13 |
2001-07-24 |
3M Innovative Properties Company |
Medicinal aerosol formulation of ciclesonide and related compounds
|
US6451285B2
(en)
*
|
1998-06-19 |
2002-09-17 |
Baker Norton Pharmaceuticals, Inc. |
Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
|
TW465235B
(en)
|
1998-09-17 |
2001-11-21 |
United Video Properties Inc |
Electronic program guide with digital storage
|
DZ2947A1
(fr)
|
1998-11-25 |
2004-03-15 |
Chiesi Farma Spa |
Inhalateur à compteur de dose sous pression.
|
US6290930B1
(en)
|
1998-12-18 |
2001-09-18 |
Baker Norton Pharmaceuticals, Inc. |
Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
|
IT1313553B1
(it)
|
1999-07-23 |
2002-09-09 |
Chiesi Farma Spa |
Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
|
IT1317846B1
(it)
|
2000-02-22 |
2003-07-15 |
Chiesi Farma Spa |
Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
|
DK1280520T4
(en)
|
2000-05-10 |
2018-06-25 |
Novartis Ag |
Phospholipid based powders for drug delivery
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
ME00220B
(me)
|
2000-05-22 |
2010-10-10 |
Chiesi Farm Spa |
Stabilne farmaceutske formulacije rastvora za inhalatore odmjerene doze pod pritiskom
|
US6451287B1
(en)
|
2000-05-26 |
2002-09-17 |
Smithkline Beecham Corporation |
Fluorinated copolymer surfactants and use thereof in aerosol compositions
|
GB0016876D0
(en)
*
|
2000-07-11 |
2000-08-30 |
Astrazeneca Ab |
Novel formulation
|
US7217409B2
(en)
|
2000-09-22 |
2007-05-15 |
Smithkline Beecham Corporation |
Alkanoic acid derivatives
|
KR100881258B1
(ko)
|
2000-12-22 |
2009-02-05 |
글락소 그룹 리미티드 |
살메테롤 지나포에이트를 위한 정량식 흡입기
|
US7905230B2
(en)
|
2001-05-09 |
2011-03-15 |
Novartis Ag |
Metered dose inhaler with lockout
|
SI1273292T1
(en)
|
2001-07-02 |
2004-12-31 |
Chiesi Farmaceutici S.P.A. |
Optimised formulation of tobramycin for aerosolization
|
GB0208742D0
(en)
|
2002-04-17 |
2002-05-29 |
Bradford Particle Design Ltd |
Particulate materials
|
WO2003013610A2
(en)
*
|
2001-08-03 |
2003-02-20 |
Glaxo Group Limited |
Surfactant compounds and uses thereof
|
GB0125127D0
(en)
|
2001-10-19 |
2001-12-12 |
Glaxo Group Ltd |
Compounds
|
GB0128148D0
(en)
|
2001-11-23 |
2002-01-16 |
Innovata Biomed Ltd |
Assembly
|
EP1458360B1
(en)
|
2001-12-19 |
2011-05-11 |
Novartis AG |
Pulmonary delivery of aminoglycosides
|
US7217833B2
(en)
|
2002-02-13 |
2007-05-15 |
Glaxco Group Limited |
Carboxylic acid compounds for use as surfactants
|
GB0205327D0
(en)
|
2002-03-06 |
2002-04-17 |
Glaxo Group Ltd |
compounds
|
JP2006527237A
(ja)
|
2003-06-13 |
2006-11-30 |
アルタナ ファルマ アクチエンゲゼルシャフト |
ホルモテロールと及びシクレソニドの組合せ物
|
EP1654312B1
(en)
|
2003-08-11 |
2014-01-15 |
Glaxo Group Limited |
Pharmaceutical metered dose inhaler and methods relating thereto
|
JP5053635B2
(ja)
|
2003-08-29 |
2012-10-17 |
グラクソ グループ リミテッド |
医療用定量噴霧式吸入器及びそれに関連する方法
|
US8371292B2
(en)
|
2003-09-16 |
2013-02-12 |
Nycomed Gmbh |
Use of ciclesonide for the treatment of respiratory diseases
|
EP1595531A1
(en)
|
2004-05-13 |
2005-11-16 |
CHIESI FARMACEUTICI S.p.A. |
Stable pharmaceutical solution formulations for pressurized metered dose inhalers
|
EP1744800B1
(en)
|
2004-04-21 |
2016-06-22 |
Innovata Biomed Limited |
Inhaler
|
JP5087539B2
(ja)
|
2005-05-18 |
2012-12-05 |
ネクター セラピューティックス |
気管支内治療のためのバルブ、デバイス、および方法
|
US20070116649A1
(en)
|
2005-09-29 |
2007-05-24 |
Nektar Therapeutics |
Antibiotic formulations, unit doses, kits, and methods
|
GB0614621D0
(en)
|
2006-07-24 |
2006-08-30 |
3M Innovative Properties Co |
Metered dose dispensers
|
GB0620700D0
(en)
|
2006-10-19 |
2006-11-29 |
3M Innovative Properties Co |
Metered dose valves and dispensers
|
GB0621707D0
(en)
|
2006-10-31 |
2006-12-13 |
Univ London Pharmacy |
Formulations for delivery via pressurised metered dose inhalers
|
EP2425820B1
(en)
|
2007-02-11 |
2015-04-08 |
MAP Pharmaceuticals Inc |
Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
|
GB0712454D0
(en)
|
2007-06-27 |
2007-08-08 |
Generics Uk Ltd |
Pharmaceutical compositions
|
EP2341942A1
(en)
|
2008-09-19 |
2011-07-13 |
Nektar Therapeutics |
Polymer conjugates of therapeutic peptides
|
WO2010076339A1
(en)
|
2009-01-05 |
2010-07-08 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Means and method for the treatment of antibody deficiency diseases based on il-21 and il-21 variants
|
AR079451A1
(es)
|
2009-12-18 |
2012-01-25 |
Nycomed Gmbh |
Compuestos 3,4,4a,10b-tetrahidro-1h-tiopirano[4,3-c]isoquinolina
|
AU2011260713A1
(en)
|
2010-06-04 |
2013-01-10 |
Trifoilium Aps |
Trefoil factors (TFF) for the treatment of chronic pulmonary diseases
|
CN103221039A
(zh)
|
2010-09-09 |
2013-07-24 |
三叶草私人有限公司 |
血管生成抑制剂的气道给药
|
GB201108039D0
(en)
|
2011-05-13 |
2011-06-29 |
Mexichem Amanco Holding Sa |
Compositions
|
EP2721036B1
(en)
|
2011-06-15 |
2015-07-22 |
Takeda GmbH |
Novel 3,4,4a,10b-tetrahydro-1h-thiopyrano[4,3-c]isoquinoline compounds
|
MX2013014888A
(es)
|
2011-06-17 |
2014-02-27 |
Takeda Gmbh |
Novedosos derivados de ftalazinona-pirrolopirimidinacarboxamida.
|
GB201117621D0
(en)
|
2011-10-12 |
2011-11-23 |
Mexichem Amanco Holding Sa |
Compositions
|
GB201117619D0
(en)
|
2011-10-12 |
2011-11-23 |
Mexichem Amanco Holding Sa |
Compositions
|
GB201118188D0
(en)
|
2011-10-21 |
2011-12-07 |
3M Innovative Properties Co |
Manufacture of medicinal aerosol canisters
|
GB201210580D0
(en)
|
2012-06-14 |
2012-08-01 |
3M Innovative Properties Co |
Metered dose dispensing valve
|
GB201221063D0
(en)
|
2012-11-23 |
2013-01-09 |
3M Innovative Properties Co |
Metered dose dispensing valve
|
GB201306984D0
(en)
*
|
2013-04-17 |
2013-05-29 |
Mexichem Amanco Holding Sa |
Composition
|
WO2016018892A1
(en)
|
2014-07-29 |
2016-02-04 |
3M Innovative Properties Company |
Method of preparing a pharmaceutical composition
|
EP3383366B2
(en)
|
2015-12-04 |
2024-06-05 |
Mexichem Fluor S.A. de C.V. |
Pharmaceutical composition
|
CA3037080C
(en)
|
2016-09-19 |
2021-05-18 |
Mexichem Fluor S.A. De C.V. |
Stable pharmaceutical compositions comprising indacaterol and 1,1-difluoroethane (hfa-152a) suitable for use in metered dose inhalers (mdis)
|
BR112019005168A2
(pt)
|
2016-09-19 |
2019-06-11 |
Mexichem Fluor Sa De Cv |
composição farmacêutica, recipiente vedado, inalador de dose medida, e, métodos para tratar um paciente que sofre ou susceptível de sofrer de um distúrbio respiratório, para melhoria da estabilidade de uma composição farmacêutica e do desempenho de aerossolização de uma composição farmacêutica e para reduzir o potencial de aquecimento global de uma composição farmacêutica
|
EP3515432B1
(en)
|
2016-09-19 |
2021-08-25 |
Mexichem Fluor S.A. de C.V. |
Pharmaceutical composition comprising glycopyrrolate
|
WO2018069210A1
(en)
|
2016-10-10 |
2018-04-19 |
Takeda Gmbh |
Tetrahydrofuro[3,4-c]isoquinolines as inhibitors of pde4
|